KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Progyny (PGNY) Change in Receivables (2018 - 2025)

Progyny (PGNY) has disclosed Change in Receivables for 8 consecutive years, with -$46.5 million as the latest value for Q4 2025.

  • On a quarterly basis, Change in Receivables changed N/A to -$46.5 million in Q4 2025 year-over-year; TTM through Dec 2025 was $14.7 million, a N/A change, with the full-year FY2025 number at $5.1 million, down 48.18% from a year prior.
  • Change in Receivables was -$46.5 million for Q4 2025 at Progyny, down from $69.7 million in the prior quarter.
  • In the past five years, Change in Receivables ranged from a high of $78.4 million in Q1 2023 to a low of -$46.5 million in Q4 2025.
  • A 5-year average of $16.7 million and a median of $9.1 million in 2023 define the central range for Change in Receivables.
  • Peak YoY movement for Change in Receivables: soared 7526.59% in 2021, then tumbled 815.12% in 2022.
  • Progyny's Change in Receivables stood at $1.9 million in 2021, then crashed by 815.12% to -$13.9 million in 2022, then tumbled by 58.91% to -$22.0 million in 2023, then skyrocketed by 54.97% to -$9.9 million in 2024, then tumbled by 368.51% to -$46.5 million in 2025.
  • Per Business Quant, the three most recent readings for PGNY's Change in Receivables are -$46.5 million (Q4 2025), $69.7 million (Q1 2025), and -$9.9 million (Q3 2024).